unknown
Stage
2
Investors
About
Freya Biosciences is a clinical-stage immunology company developing therapies that target inflammation and immune dysregulation in women's health conditions such as infertility, preterm birth, and endometriosis.
Explore Freya Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.